# K092896: Rempress and Angiography Contrast Delivery System Rempress

- Pathway: 510(k) (Traditional)
- Applicant: Nemoto Kyorindo Co., Ltd.
- Decided: Oct 29, 2010 after 403 days
- Product code: DXT (Injector And Syringe, Angiographic)
- Device class: 2
- Regulation: 21 CFR 870.1650
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K860204 (1986). 3 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 5 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K963071: Angiomat Illumena, Mallinckrodt Inc., Liebel-Flarsheim Business (1997) Summary page 1.
- K860204: Angiomat 6000, Mallinckrodt Group, Inc. (1986) Summary page 1.

## Most influential descendants
- K173450: PRESS DUO elite, PRESS DUO elite AG (2018), 0 descendants of its own

## Indications for use
The contrast delivery system REMPRESS is an intravascular injection system intended for the administration of contrast media or normal saline used in conjunction with angiographic imaging procedures.

Source page: https://510kreport.com/device/K092896
Methodology: https://510kreport.com/methodology